Skip to main content
Merck KGaA logo

Merck KGaA — Investor Relations & Filings

ISIN · DE0006599905 LEI · 529900OAREIS0MOPTW25 Manufacturing
Open in API
Filings indexed 131 across all filing types
Latest filing 2023-05-11 Interim / Quarterly Rep…
Country DE Germany
Listing —

About Merck KGaA

https://www.merckgroup.com/

Merck KGaA is a global science and technology company operating through three primary business sectors: Healthcare, Life Science, and Electronics. The Healthcare division focuses on discovering, developing, and manufacturing prescription medicines for conditions such as oncology, multiple sclerosis, and infertility. The Life Science business provides researchers with laboratory tools, technologies, and services to facilitate scientific breakthroughs and biopharmaceutical manufacturing. The Electronics sector develops high-tech materials and solutions for the semiconductor and display industries. Driven by a long history of innovation, the company integrates specialized expertise to address complex global challenges, offering a diverse portfolio of products ranging from life-saving therapies to advanced materials that power modern digital infrastructure.

Recent filings

Filing Released Lang Actions
Q1 statement / Q1 financial report 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for Merck for the first quarter of 2023. It contains detailed financial tables, including net sales, EBITDA, operating cash flow, and reconciliations of financial indicators. It is a comprehensive report of financial performance for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report (RPA) as it contains the actual financial data and analysis. Q1 2023
2023-05-11 English
Annual financial report 2022
Annual Report
2023-03-03 English
Q3 statement / Q3 financial report 2022
Interim / Quarterly Report
2022-11-18 English
Half-yearly financial report 2022
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'Half-Yearly Financial Report 2022' for Merck. It contains comprehensive financial data, including consolidated income statements, balance sheets, cash flow statements, and management discussion and analysis for the first half of the fiscal year. It is not an announcement of a report (RPA) nor a simple certification (RNS), but the full interim financial report itself. H1 2022
2022-08-05 English
Q1 statement / Q1 financial report 2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for the 1st Quarter of 2022 for Merck. It contains detailed financial data, including a consolidated income statement, balance sheet, cash flow statement, and management discussion of business developments. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-12 English
Annual financial report 2021
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report 2021' and contains comprehensive financial data, a letter to shareholders, a combined management report, corporate governance details, and consolidated financial statements. It meets the criteria for a full annual report rather than an announcement or summary. FY 2021
2022-03-07 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.